320+
Hemophilia Patients Successfully Recruited
13+
Completed Hemophilia Studies
68%
Faster Enrollment Than Industry Average
97%
Patient Retention Rate in Hemophilia Trials
Hemophilia Recruitment Specializations
Comprehensive recruitment strategies for all types and severities of bleeding disorders.
Hemophilia A
Factor VIII deficiency requiring specialized replacement therapy
- Extended half-life factors
- Non-factor therapies
- Gene therapy trials
Hemophilia B
Factor IX deficiency with different treatment considerations
- Long-acting factors
- Prophylaxis studies
- Gene therapy research
Severe Hemophilia
Less than 1% factor activity with frequent bleeding episodes
- Prophylaxis protocols
- Joint preservation
- Quality of life studies
Inhibitor Patients
Patients with neutralizing antibodies to factor concentrates
- Bypassing agents
- Immune tolerance induction
- Novel therapies
Pediatric Hemophilia
Children requiring age-appropriate bleeding disorder management
- Early prophylaxis
- Joint health
- Developmental outcomes
Women with Bleeding Disorders
Female carriers and women with von Willebrand disease
- Menstrual bleeding studies
- Pregnancy management
- Hormonal therapies